Hookworm infection: New developments and prospects for control

Current Opinion in Infectious Diseases

Volumn 17, Issue 5, 2004, Pages 421-426

  Bungiro, Richard ^a   Cappello, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anemia; Hookworm; Immunology; Pathogenesis; Public health; Vaccine development

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; BENZIMIDAZOLE; MEBENDAZOLE; VACCINE;

ANEMIA; CLIMATE; DEVELOPING COUNTRY; GROWTH RETARDATION; HOOKWORM INFECTION; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; PARASITE VIRULENCE; REVIEW; SOCIOECONOMICS;

ANCYLOSTOMA; ANCYLOSTOMIASIS; ANIMALS; CRICETINAE; DRUG DESIGN; HOOKWORM INFECTIONS; HUMANS; NECATOR AMERICANUS; NECATORIASIS; VACCINES;

EID: 6444227382     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200410000-00006     Document Type: Review

References (43)

1. de Suva NR, Brooker S, Hotez PJ, et al. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol 2003; 19:547-551. This review summarizes current data on global hookworm prevalence, as well as changes that have occurred in the past decade.
2. World Health Organisation. The World Health Report 2002: reducing risks, promoting healthy life. Geneva: World Health Organisation; 2002.
3. Despommier DD, Gwadz RW, Hotez PJ, Knirsch CA. In: The Hookworms. Parasitic Diseases. New York: Apple Trees Productions, LLC; 2000. pp. 111-118.
4. Hotez PJ. Hookworm disease in children. Pediatr Infect Dis J 1989; 8:516-520.
5. Cappello M, Harrison LM, Bungiro RD Jr, et al. Molecular pathogenesis of hookworm anemia: prospects for a disease-based vaccine. J Parasitol 2003; 89:S158-S164. This review describes the major features of the hamster model of A. ceylanicum hookworm pathogenesis and vaccine development.
6. Sinuon M, Anantaphruti MT, Socheat D. Intestinal helminthic infections in schoolchildren in Cambodia. Southeast Asian J Trop Med Public Health 2003; 34:254-258. This study demonstrates the broad range of intensity of hookworm infection within endemic communities.
7. van der Hoek W, De NV, Konradsen F, et al. Current status of soil-transmitted helminths in Vietnam. Southeast Asian J Trop Med Public Health 2003; 34 (Suppl 1): 1-11. This study demonstrates the broad range of intensity of hookworm infection within endemic communities.
8. Mabaso ML, Appleton CC, Hughes JC, Gouws E. The effect of soil type and climate on hookworm (Necator americanus) distribution in KwaZulu-Natal, South Africa. Trop Med Int Health 2003; 8:722-727.
9. Utzinger J, Muller I, Vounatsou P, et al. Random spatial distribution of Schistosoma mansoni and hookworm infections among school children within a single village. J Parasitol 2003; 89:686-692.
10. Tomono N, Anantaphruti MT, Jongsuksuntigul P, et al. Risk factors of helminthiases among schoolchildren in southern Thailand. Southeast Asian J Trop Med Public Health 2003; 34:264-268.
11. Traub RJ, Robertson ID, Irwin P, et al. The prevalence, intensities and risk factors associated with geohelminth infection in tea-growing communities of Assam, India. Trop Med Int Health 2004; 9:688-701.
12. Loukas A, Prociv P. Immune responses in hookworm infections. Clin Microbiol Rev 2001; 14:689-703.
13. Geiger SM, Massara CL, Bethony J, et al. Cellular responses and cytokine production in post-treatment hookworm patients from an endemic area in Brazil. Clin Exp Immunol 2004; 136:334-340. This paper is one of the only detailed investigations of inflammatory immune responses to hookworm infection.
14. Bashir ME, Andersen P, Fuss IJ, et al. An enteric helminth infection protects against an allergic response to dietary antigen. J Immunol 2002; 169:3284-3292.
15. Cooper PJ, Chico ME, Rodrigues LC, et al. Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics. J Allergy Clin Immunol 2003; 111:995-1000. This study demonstrates that chronic geohelminth infection is associated with an apparent reduction in allergic-type disease.
16. Dagoye D, Bekele Z, Woldemichael K, et al. Wheezing, allergy, and parasite infection in children in urban and rural Ethiopia. Am J Respir Crit Care Med 2003; 167:1369-1373.
17. Loeb L, Fleisher MS. The influence of extracts of Anchylostoma caninum on the coagulation of the blood and on hemolysis. J Infect Dis 1910; 7:625-631.
18. Mieszczanek J, Harrison LM, Vlasuk GP, Cappello M. Anticoagulant peptides from Ancylostoma caninum are immunologically distinct and localize to separate structures within the adult hookworm. Mol Biochem Parasitol 2004; 133:319-323. This study confirms that the anticoagulants from A. caninum likely have complementary, rather than redundant functions in vivo.
19. Del Valle A, Jones BF, Harrison LM, et al. Isolation and molecular cloning of a secreted hookworm platelet inhibitor from adult Ancylostoma caninum. Mol Biochem Parasitol 2003; 129:167-177.
20. Mieszczanek J, Harrison LM, Cappello M. Ancylostoma ceylanicum anticoagulant peptide-1: role of the predicted reactive site amino acid in mediating inhibition of coagulation factors Xa and VIIa. Mol Biochem Parasitol 2004 (in press).
21. Geisbert TW, Hensley LE, Jahrling PB, et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet 2003; 362:1953-1958. The hookworm anticoagulant NAPc2 prolonged survival in a non-human primate model of Ebola virus infection.
22. Lee AY, Vlasuk GP. Recombinant nematode anticoagulant protein c2 and other inhibitors targeting blood coagulation factor VIIa/tissue factor. J Intern Med 2003; 254:313-321.
23. Williamson AL, Brindley PJ, Knox DP, et al. Digestive proteases of blood-feeding nematodes. Trends Parasitol 2003; 19:417-423. This detailed review outlines the potential role of nematode protease in digestion.
24. Williamson AL, Lecchi PX, Turk BE, et al. A multi-enzyme cascade of hemoglobin proteolysis in the intestine of blood-feeding hookworms. J Biol Chem 2004 (in press).
25. Williamson AL, Brindley PJ, Abbenante G, et al. Hookworm aspartic protease, Na-APR-2, cleaves human hemoglobin and serum proteins in a host-specific fashion. J Infect Dis 2003; 187:484-494.
26. Williamson AL, Brindley PJ, Abbenante G, et al. Cleavage of hemoglobin by hookworm cathepsin D aspartic proteases and its potential contribution to host specificity. FASEB J 2002; 16:1458-1460.
27. Milstone AM, Harrison LM, Bungiro RD, et al. A broad spectrum kunitz type serine protease inhibitor secreted by the hookworm Ancylostoma ceylanicum. J Biol Chem 2000; 275:29391-29399.
28. Chu D, Bungiro RD, Ibanez M, et al. Molecular characterization of Ancylostoma ceylanicum Kunitz-type serine protease inhibitor: evidence for a role in hookworm-associated growth delay. Infect Immun 2004; 72:2214-2221. This paper confirms the role of AceKl in the pathogenesis of hookworm-associated growth delay.
29. Hotez PJ, Zhan B, Bethony JM, et al. Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative, Int J Parasitol 2003; 33:1245-1258. This review summarizes hookworm vaccine candidates, and outlines progress and future challenges for successful vaccine development.
30. Zhan B, Liu Y, Badamchian M, et al. Molecular characterisation of the Ancylostoma-secreted protein family from the adult stage of Ancylostoma caninum. Int J Parasitol 2003; 33:897-907. This paper characterizes the multiple members of the ASP family from adult A. caninum.
31. Moyle M, Foster DL, McGrath DE, et al. A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CD11b/CD18. J Biol Chem 1994; 269:10008-10015.
32. Bungiro RD, Harrison LM, Cappello M. Ancylostoma ceylanicum excretory/secretory protein 1: purification and molecular cloning of a major secretory protein from adult hookworms. Mol Biochem Parasital 2002; 119:147-151.
33. Bungiro RD Jr, Solis CV, Harrison LM, Cappello M. Purification and molecular cloning of and immunization with Ancylostoma ceylanicum excretory-secretory protein 2, an immunoreactive protein produced by adult hookworms. Infect Immun 2004; 72:2203-2213. This study demonstrates that oral immunization with an immunodominant adult worm secretory protein confers partial protection against hookworm anemia.
34. de Suva NR. Impact of mass chemotherapy on the morbidity due to soil-transmitted nematodes. Acta Trap 2003; 86:197-214.
35. Urbani C, Albonico M. Anthelminthic drug safety and drug administration in the control of soil-transmitted helminthiasis in community campaigns. Acta Trop 2003; 86:215-221.
36. Friis H, Mwaniki D, Omondi B, et al. Effects on haemoglobin of multi-micronutrient supplementation and multi-helminth chemotherapy, a randomized, controlled trial in Kenyan school children. Eur J Clin Nutr 2003; 57:573-579.
37. Bhargava A, Jukes M, Lambo J, et al. Anthelmintic treatment improves the hemoglobin and serum ferritin concentrations of Tanzanian schoolchildren. Food Nutr Bull 2003; 24:332-342.
38. Stotefus RJ, Chway HM, Montresor A, et al. Low dose daily iron supplementation improves iron status and appetite but not anemia, whereas quarterly anthelminthic treatment improves growth, appetite and anemia in Zanzibari preschool children. J Nutr 2004; 134:348-356. This is an important study that demonstrates short-term benefit of anthelminthic therapy in young children.
39. Albonico M, Bickle Q, Ramsan M, et al. Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull World Hearth Org 2003; 81:343-352. This study reports a reduction in the efficacy of mebendazole during a period of extensive use within an endemic community. It considers the possibility that benzimidazole resistance has emerged.
40. Albonico M, Wright V, Bickle Q. Molecular analysis of the beta-tubulin gene of human hookworms as a basis for possible benzimidazole resistance on Pemba Island. Mol Biochem Parasitai 2004; 134:281-284.
41. Hotez PJ, Ashcom J, Zhan B, et al. Effect of vaccination with a recombinant fusion protein encoding an astacinlike metalloprotease (MTP-1) secreted by host-stimulated Ancylostoma caninum third-stage infective larvae. J Parasitol 2003; 89:853-855.
42. Loukas A, Bethony JM, Williamson AL, et al. Vaccination of dogs with a recombinant cysteine protease from the intestine of canine hookworms diminishes the fecundity and growth of worms. J Infect Dis 2004; 189:1952-1961. Study reports that immunization with an adult worm protease is associated with reduction in adult worm size and fecundity, without impact on worm burden.
43. Bungiro RD Jr, Greene J, Kruglov E, Cappello M. Mitigation of hookworm disease by immunization with soluble extracts of Ancylostoma ceylanicum. J Infect Dis 2001; 183:1380-1387.